After adjustment for potential confounding elements, COVID-19 sufferers had a decrease danger of requiring take care of migraine (-35%), epilepsy (-22%), neuropathy (-44%), motion issues (-36%), stroke (-10%), and dementia (-7%) than the flu cohort.
The research did not particularly study long-COVID outcomes, and the findings do not essentially battle with these of earlier research displaying elevated neurologic signs in long-COVID sufferers, the authors famous. Additionally, the outcomes might not apply to all COVID-19 survivors as a result of the studied pattern wasn’t nationally consultant.
“Whereas the outcomes weren’t what we anticipated to seek out, they’re reassuring in that we discovered being hospitalized with COVID didn’t result in extra take care of widespread neurologic situations when in comparison with being hospitalized with influenza,” coauthor Brian Callaghan, MD, MS, of the College of Michigan Well being at Ann Arbor, stated in a press launch from the American Academy of Neurology, writer of Neurology.
It is reassuring that COVID-19 behaves equally to different respiratory viruses with respect to the studied neurologic situations, the authors stated. “There was concern that the already restricted entry to neurologic care would additional shrink if we had a dramatic enhance in neurologic care after COVID-19 an infection,” lead creator Adam de Havenon, MD, MSc, of Yale, stated within the launch.